Document is current
Any future updates will be listed below
-
Authors
Joyce, Elizabeth https://orcid.org/0000-0002-8133-2298
Carr, Grant
Wang, Sidi
Brummett, Chad M.
Kidwell, Kelley M.
Henry, N. Lynn https://orcid.org/0000-0002-4771-5930
-
Funding
Funding for this research was provided by:
National Cancer Institute (1R01CA266012-01)
Center for Biomedical Informatics and Information Technology, National Cancer Institute (5T32CA083654)
National Center for Advancing Translational Sciences (5TL1TR002242)
- License Information
-
More Information
Article History
Received: 28 September 2022
Accepted: 3 November 2022
First Online: 13 November 2022
Declarations
:
: NLH reports research contracting to her institution from Blue Note Therapeutics, consulting from Myovant Pharmaceuticals, and royalties from Up-to-Date, none of which are related to this work. CMB is a consultant for Heron Therapeutics, Vertex Pharmaceuticals, Alosa Health and Benter Foundation; and he provides expert medical testimony, none of which are related to this work. The remaining authors have no disclosures to report.
: MGI was approved by the Institutional Review Board at the University of Michigan (IRBMED; HUM00028683), and this exploratory analysis was granted an exemption from IRBMED (HUM00169453).
: Informed consent was obtained from all individual participants included in the MGI study for participation and publishing.
